Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanan Zheng

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|July 1, 2021
Long Noncoding RNA SNHG12 Promotes Gastric Cancer Proliferation by Binding to HuR and Stabilizing YWHAZ Expression Through the AKT/GSK-3β PathwayTianqi Zhang, Maneesh Kumarsing Beeharry, Yanan Zheng, et al.
Journal of Medicinal Chemistry|August 22, 2023
Discovery of Highly Selective and Orally Bioavailable PI3Kδ Inhibitors with Anti-Inflammatory Activity for Treatment of Acute Lung InjuryYongmei Tang, Fanli Zheng, Xiaodong Bao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 30, 2018
An integrated approach to uncover quality marker underlying the effects of Alisma orientale on lipid metabolism, using chemical analysis and network pharmacologyMaoliang Liao, Haihua Shang, Yazhuo Li, et al.
BMC Cancer|December 8, 2022
ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancerMei Li, Yanan Zheng, Xujun Li, et al.
Annals of Translational Medicine|January 25, 2021
Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinomaYanan Zheng, Zhenqiang Wang, Chao Yan, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 25, 2023
CoFe Alloys Dispersed on Se, N Co-Doped Graphitic Carbon as Efficient Bifunctional Catalysts for Zn-Air BatteriesLonghua Dai, Chuanzhen Feng, Yangjun Luo, et al.
The Journal of Organic Chemistry|March 25, 2021
Catalyst-Free and Transition-Metal-Free Approach to 1,2-Diketones via Aerobic Alkyne OxidationDuyi Shen, Hongyan Wang, Yanan Zheng, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 13, 2025
Prognostic value of PLN, LNR, and LODDS in advanced colorectal signet ring cell carcinomaLiang Chu, Cenzhu Wang, Han Wang, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Camrelizumab and apatinib combined with chemotherapy in perioperative effective therapy for advanced gastric carcinoma with peritoneal metastasis: a case reportSong Liang, Xinan Fang, Pin Jiang, et al.
Journal of Clinical Pharmacology|December 28, 2020
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe AsthmaNeang Ly, Yanan Zheng, Janet M Griffiths, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|July 1, 2021
Long Noncoding RNA SNHG12 Promotes Gastric Cancer Proliferation by Binding to HuR and Stabilizing YWHAZ Expression Through the AKT/GSK-3β PathwayTianqi Zhang, Maneesh Kumarsing Beeharry, Yanan Zheng, et al.
Journal of Medicinal Chemistry|August 22, 2023
Discovery of Highly Selective and Orally Bioavailable PI3Kδ Inhibitors with Anti-Inflammatory Activity for Treatment of Acute Lung InjuryYongmei Tang, Fanli Zheng, Xiaodong Bao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 30, 2018
An integrated approach to uncover quality marker underlying the effects of Alisma orientale on lipid metabolism, using chemical analysis and network pharmacologyMaoliang Liao, Haihua Shang, Yazhuo Li, et al.
BMC Cancer|December 8, 2022
ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancerMei Li, Yanan Zheng, Xujun Li, et al.
Annals of Translational Medicine|January 25, 2021
Protocol for a randomized controlled trial of perioperative S-1 plus oxaliplatin combined with apatinib and camrelizumab in patients with resectable, locally advanced gastric or gastroesophageal junction adenocarcinomaYanan Zheng, Zhenqiang Wang, Chao Yan, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 25, 2023
CoFe Alloys Dispersed on Se, N Co-Doped Graphitic Carbon as Efficient Bifunctional Catalysts for Zn-Air BatteriesLonghua Dai, Chuanzhen Feng, Yangjun Luo, et al.
The Journal of Organic Chemistry|March 25, 2021
Catalyst-Free and Transition-Metal-Free Approach to 1,2-Diketones via Aerobic Alkyne OxidationDuyi Shen, Hongyan Wang, Yanan Zheng, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 13, 2025
Prognostic value of PLN, LNR, and LODDS in advanced colorectal signet ring cell carcinomaLiang Chu, Cenzhu Wang, Han Wang, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Camrelizumab and apatinib combined with chemotherapy in perioperative effective therapy for advanced gastric carcinoma with peritoneal metastasis: a case reportSong Liang, Xinan Fang, Pin Jiang, et al.
Journal of Clinical Pharmacology|December 28, 2020
Pharmacokinetic and Pharmacodynamic Modeling of Tezepelumab to Guide Phase 3 Dose Selection for Patients With Severe AsthmaNeang Ly, Yanan Zheng, Janet M Griffiths, et al.
Pageof 13